ArticleBMC public health2025
Prevalence of neutropenia in the U.S. among reproductive-aged women: a population-based analysis of NHANES 2013-2020.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system.Therapeutic advances in psychopharmacology · 2026Article
- Association between high-density lipoprotein cholesterol-related inflammatory markers and female infertility: a cross-sectional analysis from the National Health and Nutrition Examination Survey (NHANES 2013-2018).BMC women's health · 2025Article
- Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundInfertility is one of the prominent public health concerns nationwide. Neutrophils, despite their established significance as vital players in both inflammatory and immune processes, have been studied scarcely in terms of their effect on female infertility. The present study aimed to determine the prevalence of neutropenia among women of reproductive age in the U.S. to contribute valuable insights to the broader context of reproductive health.
methodsThe present study was designed as a cross-sectional investigation. The data of 5,250 female participants aged 18-45 years were obtained from the National Health and Nutrition Examination Survey (NHANES) conducted between the years 2013 and 2020. The representativeness of the population was ensured by conducting statistical assessments based on NHANES weights. A logistic regression model was established to assess the hematologic parameters across the distinct populations stratified according to age, ethnicity, smoking status, and infertility. Multivariate logistic regression was performed next, and weighted odds ratios along with the 95% confidence interval values were calculated, which assisted in predicting the prevalence of neutropenia among the female participants.
resultsThe data of a total of 5,250 female participants, representing a multiracial population of 51.17 million in the United States, were analyzed in the present study. Meanwhile, the estimated neutropenia incidence was 7.09% (95% CI: 6.16-8.01%), which indicated a prevalence among approximately 36.2 million U.S. citizens. In comparison to white subjects, black subjects exhibited a significantly lower average leukocyte count, with a mean difference (MD) of 1.16 × 10
conclusionsNeutropenia appears to have a higher prevalence in the general population compared to that acknowledged previously. The findings of the present study indicated association between neutropenia and infertility. This highlighted the importance of directing increased attention toward neutropenia in the context of both research and clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.